In the realm of multiple myeloma treatment, autologous peripheral blood stem cell transplantation (aPBSCT) stands as a beacon of hope, offering patients a chance at remission and prolonged survival. However, the efficacy of this procedure relies heavily on the quality and quantity of harvested stem cells. Driven by a commitment to enhance outcomes for multiple myeloma patients, this comprehensive guide delves deep into the intricacies of aPBSCT, uncovering innovative strategies and essential cutoff values to optimize the transplantation process. Written with precision and expertise, "Optimizing Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma" is a groundbreaking exploration into the forefront of stem cell research. Authored by leading experts in the field, this book offers a meticulous analysis of alternative determinants and cutoff values, shedding light on novel approaches to stem cell harvesting. From post-mobilization day 8 assessments to hematopoietic progenitor cell counts, every facet of aPBSCT optimization is meticulously dissected, providing clinicians and researchers with invaluable insights into improving patient outcomes. Through a synthesis of cutting-edge research and clinical expertise, this book demystifies the complexities of stem cell transplantation, offering practical guidance for healthcare professionals navigating the challenges of multiple myeloma treatment.